Browse
Submit Data
Databases
API
Help

Dataset Information

30 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1,3,5-Tris(2H-tetra-zol-5-ylmeth-oxy)-benzene.

ABSTRACT: The title compound, C(12)H(12)N(12)O(3), was obtained by the hydro-thermal reaction of 1,3,5-tricyano-methoxy-benzene and (CH(3))(3)SiN(3). The mol-ecule is almost planar, with an r.m.s. deviation of 0.0976?Å from the plane through all atoms in the mol-ecule. The three tetra-zole rings make dihedral angles of 13.09?(19), 2.01?(19) and 11.56?(18)° with one another and corresponding angles of 8.66?(17), 5.44?(16) and 3.51?(17)° with the central benzene ring. In the crystal structure, inter-molecular N-H?N hydrogen bonds form well separated one-dimensional planar sheets.

SUBMITTER: Luo HZ

PROVIDER: S-EPMC2915205 | biostudies-literature | 2007 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

1,3,5-Tris(2H-tetra-zol-5-ylmeth-oxy)-benzene.

Luo Hui-Zhou HZ Ye Heng-Yun HY

Acta crystallographica. Section E, Structure reports online 20071206 Pt 1

The title compound, C(12)H(12)N(12)O(3), was obtained by the hydro-thermal reaction of 1,3,5-tricyano-methoxy-benzene and (CH(3))(3)SiN(3). The mol-ecule is almost planar, with an r.m.s. deviation of 0.0976 Å from the plane through all atoms in the mol-ecule. The three tetra-zole rings make dihedral angles of 13.09 (19), 2.01 (19) and 11.56 (18)° with one another and corresponding angles of 8.66 (17), 5.44 (16) and 3.51 (17)° with the central benzene ring. In the crystal structure, inter-molecul ...[more]

PMID: 21200700

Similar Datasets

1,3,5-Tris{[3-(1H-benzotriazol-1-ylmeth-yl)phen-oxy]meth-yl}-2,4,6-trimethyl-benzene.

Project description:In the title compound, C(51)H(45)N(9)O(3), three 1-(1H-benzotriazol-1-ylmeth-yl)-3-phen-yloxy (bmph) ligands are bonded to the central benzene ring in an asymmetric arrangement, two bmph located on one side of the central benzene ring and the other bmph located on the opposite side of the central benzene ring. The dihedral angles between the central benzene ring and the three pendant phenoxy rings are 76.71?(14), 67.81?(13) and 70.67?(16)°. In the crystal structure, one bmph is disordered over two sites in a 0.611?(5):0.389?(5) ratio. Some of the methyl H atoms are equally disordered over two sets of sites. Inter-molecular C-H?N hydrogen bonding is present in the crystal structure.

| S-EPMC2959237 | biostudies-literature

1,3,5-Tris(6-chloro-pyrazin-2-yl-oxy)benzene.

Project description:In the title compound, C(18)H(9)Cl(3)N(6)O(3), all bond lengths and angles are normal. The dihedral angles between the benzene ring and the three pyrazine rings are 72.67 (2), 60.73 (3) and 77.74 (2)°. The crystal packing is stabilized by van der Waals forces and by a weak π-π stacking inter-action between pyrazine rings, with a centroid-centroid distance of 3.487 (2) Å.

| S-EPMC2915235 | biostudies-literature

4-[5-(3-Pyrid-yl)-2H-tetra-zol-2-ylmeth-yl]benzonitrile.

Project description:In the title compound, C(14)H(10)N(6), the pyridine and tetra-zole rings are nearly coplanar and are twisted from each other by a dihedral angle of only 0.86?(9)°. The benzene ring makes a dihedral angle of 70.55?(6)° with the tetra-zole ring.

| S-EPMC2961461 | biostudies-literature

Benzene-1,3,5-tricarb-oxy-lic acid-5-(pyridin-1-ium-3-yl)-5H-1,2,3,4-tetra-zol-5-ide (1/1).

Project description:The asymmetric unit of the title compound, C(6)H(5)N(5)·C(9)H(6)O(6), comprises a full mol-ecule each of neutral trimesic acid (tma) and zwitterionic 5-(pyridin-1-ium-3-yl)-5H-1,2,3,4-tetra-zol-5-ide (ptz). The components are linked into a two-dimensional layer by a combination of O-H?O, O-H?N, N-H?O and N-H?N hydrogen bonds parallel to the (10[Formula: see text]) plane. Layers comprising alternating rows of tma and ptz are linked into a three-dimensional network by C-H?O and ?-? inter-actions between tma and tetra-zolate rings [centroid-centroid distance = 3.763?(2)?Å], and between pyridinium and tetra-zolate rings [centroid-centroid distance = 3.745?(2)?Å].

| S-EPMC3151784 | biostudies-literature

2-{4-[5-(3-Pyrid-yl)-2H-tetra-zol-2-ylmeth-yl]phen-yl}benzonitrile.

Project description:In the title compound, C(20)H(14)N(6), there are two mol-ecules with similar conformations in the asymmetric unit. The pyridine and tetra-zole rings are nearly coplanar; they are twisted from each other by dihedral angles of only 8.7 (2) and 7.4 (2)°. The nearer benzene ring makes dihedral angles of 69.9 (2) and 88.5 (2)° with the tetra-zole ring in the two mol-ecules.

| S-EPMC2962075 | biostudies-literature

1,3,5-Tris(bromo-meth-yl)-2,4,6-trimeth-oxy-benzene.

Project description:There are three independent mol-ecules in the asymmetric unit of the title compound, C12H15Br3O3, two of which have approximate trigonal symmetry, the third being conformationally different as it adopts near mirror symmetry. The crystal structure features C-H?Br inter-actions, a weak C-H?O hydrogen bond, ?-? inter-actions [minimum ring centroid separation = 3.4927?(18)?Å] and a short Br?Br contact [3.5894?(5)?Å], resulting in a three-dimensional supramolecular network.

| S-EPMC3647873 | biostudies-other

Tris{4-[(2H-tetra-zol-5-yl)meth-yl]morpholinium} dodeca-tungstophosphate hexa-hydrate.

Project description:The title heteropolyoxidotungstate-based inorganic-organic hybrid material, (C(6)H(12)N(5)O)(3)[W(12)(PO(4))O(36)]·6H(2)O, consists of one α-Keggin-type [W(12)(PO(4))O(36)](3-) polyoxidometalate anion (POM), three crystallographically independent 4-[(2H-tetra-zol-5-yl)meth-yl]morpholinium cations and six water mol-ecules of crystallization. The morpholine ring of the cation adopts a chair conformation. The anion shows characteristic features with respect to bond lengths and angles. An extensive network of N-H⋯O, N-H⋯N, O-H⋯O and O-H⋯N hydrogen-bonding inter-actions between the organic cations, inorganic anion and the crystal water mol-ecules lead to a three-dimensional structure. Moreover, six uncoordinated water mol-ecules increase the number of hydrogen bonds in the network and lead to the formation of (H(2)O)(∞) clusters.

| S-EPMC3052096 | biostudies-literature

2,4,6-Trimethyl-1,3,5-tris-(morpholino-meth-yl)benzene.

Project description:In the title compound, C(24)H(39)N(3)O(3), the H atoms of the methyl groups are disordered over two positions, with site-occupation factors fixed at 0.5. The three morpholino groups are arranged in an asymmetrical fashion with respect to the anchoring mesitylene ring and adopt chair conformations. Inter-molecular C-H?? inter-actions link the mol-ecules into a one-dimensional chain structure.

| S-EPMC2961465 | biostudies-literature

1,3,5-Tris(4-meth-oxy-phen-yl)-1,3,5-triazinane-2,4,6-trione.

Project description:The complete mol-ecule of the title compound, C24H21N3O6, is generated by the application of threefold rotation symmetry about an axis perpendicular to the central ring. The mol-ecule exhibits a propeller-like shape. The dihedral angle between each benzene ring and the heterocyclic ring is 74.0 (1)°. The mol-ecules pack with no specific inter-molecular inter-actions between them. The SQUEEZE procedure in PLATON [Spek (2009 ▶). Acta Cryst. D65, 148-155] was used to model disordered solvent mol-ecules, presumed to be acetone; the calculated unit-cell data do not take into account the presence of these.

| S-EPMC3998286 | biostudies-literature

2,2',2''-[(2,4,6-Trimeth-oxy-benzene-1,3,5-tri-yl)tris-(methyl-ene)]tris-(isoindole-1,3-dione).

Project description:The title mol-ecule, C36H27N3O9, adopts an almost symmetric conformation in which the mean planes of the phthalimido units are inclined at dihedral angles of 81.1?(1), 85.3?(1) and 86.3?(1)° with respect to the plane of the central aromatic ring. The O atoms are involved in intra- and inter-molecular C-H?O hydrogen bonding. The crystal structure also features ?-? arene inter-actions [minimum ring centroid separation = 3.683?(2)?Å]. The present mode of non-covalent interactions leads to a three-dimensional supramolecular architecture.

| S-EPMC3647874 | biostudies-other

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data